The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Chemotherapeutic Drugs Inhibit Ribosome Biogenesis at Various Levels
Open accessAbstract
Drugs for cancer therapy belong to different categories of chemical substances. The cellular targets for the therapeutic efficacy are often not unambiguously identified. Here, we describe the process of ribosome biogenesis as a target of a large variety of chemotherapeutic drugs. We determined the inhibitory concentration of 36 chemotherapeutic drugs for transcription and processing of ribosomal RNA by in vivo labeling experiments. Inhibitory drug concentrations were correlated to the loss of nucleolar integrity. The synergism of drugs inhibiting ribosomal RNA synthesis at different levels was studied. Drugs inhibited ribosomal RNA synthesis either at the level of (i) rRNA transcription (e.g. oxaliplatin, doxorubicin, mitoxantrone, methotrexate), (ii) early rRNA processing (e.g. camptothecin, flavopiridol, roscovitine), or (iii) late rRNA processing (e.g. 5-fluorouracil, MG-132, homoharringtonine). Blockage of rRNA transcription or early rRNA processing steps caused nucleolar disintegration, whereas blockage of late rRNA processing steps left the nucleolus intact. Flavopiridol and 5-fluorouracil showed a strong synergism for inhibition of rRNA processing. We conclude that inhibition of ribosome biogenesis by chemotherapeutic drugs potentially may contribute to the efficacy of therapeutic regimens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
5-Fluorouracil: mechanisms of action and clinical strategies
Longley, D. B., Harkin, D. P., & Johnston, P. G. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1074 · Cited by 5,332
Disruption of p53 in human cancer cells alters the responses to therapeutic agents.
Bunz, F., Hwang, P. M., Torrance, C., Waldman, T., Zhang, Y., Dillehay, L., Williams, J., Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6863 · Cited by 1,044
The Chemical Genomic Portrait of Yeast: Uncovering a Phenotype for All Genes
Hillenmeyer, M. E., Fung, E., Wildenhain, J., Pierce, S. E., Hoon, S., Lee, W., Proctor, M., St.Onge, R. P., Tyers, M., Koller, D., et al. (2008) · Science · doi:10.1126/science.1150021 · Cited by 1,003
Rubbi, C. P. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg579 · Cited by 811
RNA Exosome Depletion Reveals Transcription Upstream of Active Human Promoters
Preker, P., Nielsen, J., Kammler, S., Lykke-Andersen, S., Christensen, M. S., Mapendano, C. K., Schierup, M. H., & Jensen, T. H. (2008) · Science · doi:10.1126/science.1164096 · Cited by 791
Regulation of HDM2 activity by the ribosomal protein L11
Lohrum, M. A. E., Ludwig, R. L., Kubbutat, M. H. G., Hanlon, M., & Vousden, K. H. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00134-x · Cited by 623
Dai, M.-S., Zeng, S. X., Jin, Y., Sun, X.-X., David, L., & Lu, H. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.17.7654-7668.2004 · Cited by 489
Lum, P. Y., Armour, C. D., Stepaniants, S. B., Cavet, G., Wolf, M. K., Butler, J. S., Hinshaw, J. C., Garnier, P., Prestwich, G. D., Leonardson, A., et al. (2004) · Cell · doi:10.1016/s0092-8674(03)01035-3 · Cited by 481
Metabolism and mechanism of action of 5-fluorouracil
Parker, W. B., & Cheng, Y. C. (1990) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(90)90056-8 · Cited by 451
Dynamic Sorting of Nuclear Components into Distinct Nucleolar Caps during Transcriptional Inhibition
Shav-Tal, Y., Blechman, J., Darzacq, X., Montagna, C., Dye, B. T., Patton, J. G., Singer, R. H., & Zipori, D. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-11-0992 · Cited by 400
Byrd, J. C., Lin, T. S., Dalton, J. T., Wu, D., Phelps, M. A., Fischer, B., Moran, M., Blum, K. A., Rovin, B., Brooker-McEldowney, M., et al. (2007) · Blood · doi:10.1182/blood-2006-05-020735 · Cited by 390
Repression of RNA Polymerase I Transcription by the Tumor Suppressor p53
Zhai, W., & Comai, L. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.16.5930-5938.2000 · Cited by 289
Yuan, X., Zhou, Y., Casanova, E., Chai, M., Kiss, E., Gröne, H.-J., Schütz, G., & Grummt, I. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.05.023 · Cited by 250
Modifications of U2 snRNA are required for snRNP assembly and pre-mRNA splicing
Yu, Y.-T. (1998) · The EMBO Journal · doi:10.1093/emboj/17.19.5783 · Cited by 249
Hölzel, M., Rohrmoser, M., Schlee, M., Grimm, T., Harasim, T., Malamoussi, A., Gruber-Eber, A., Kremmer, E., Hiddemann, W., Bornkamm, G. W., et al. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200501141 · Cited by 205
Self-citation5-Fluorouracil Activation of p53 Involves an MDM2-Ribosomal Protein Interaction
Sun, X.-X., Dai, M.-S., & Lu, H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610621200 · Cited by 199
A role for c-Myc in the regulation of ribosomal RNA processing
Schlosser, I. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg794 · Cited by 182
Lindström, M. S., Jin, A., Deisenroth, C., Wolf, G. W., & Zhang, Y. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01307-06 · Cited by 177
Cooperation between the ribosomal proteins L5 and L11 in the p53 pathway
Horn, H. F., & Vousden, K. H. (2008) · Oncogene · doi:10.1038/onc.2008.189 · Cited by 162
p53 represses ribosomal gene transcription
Budde, A., & Grummt, I. (1999) · Oncogene · doi:10.1038/sj.onc.1202402 · Cited by 157
Cyclin-dependent kinases govern formation and maintenance of the nucleolus
Sirri, V., Hernandez‐Verdun, D., & Roussel, P. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200201024 · Cited by 152
Michaela, R., Hölzel, M., Thomas, G., Anastassia, M., Thomas, H., Orban, M., Pfisterer, I., Anita, G.-E., Kremmer, E., & Eick, D. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00172-07 · Cited by 140
Self-citationLinking uracil base excision repair and 5-fluorouracil toxicity in yeast
Seiple, L. A. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj430 · Cited by 127
Gagnon-Kugler, T., Langlois, F., Stefanovsky, V. Y., Lessard, F., & Moss, T. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.07.008 · Cited by 122
The Role of dUTPase and Uracil-DNA Repair in Cancer Chemotherapy
Ladner, R. D. (2001) · Current Protein and Peptide Science · doi:10.2174/1389203013380991 · Cited by 116
Ghoshal, K., & Jacob, S. T. (1994) · PubMed · Cited by 101
Grimm, T. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl378 · Cited by 95
5-Fluorouracil Enhances Exosome-Dependent Accumulation of Polyadenylated rRNAs
Fang, F., Hoskins, J. W., & Butler, J. S. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.24.10766-10776.2004 · Cited by 95
Zhao, X., & Yu, Y. (2004) · RNA · doi:10.1261/rna.5159504 · Cited by 92
Incorporation of 5-fluorouracil into U2 snRNA blocks pseudouridylation and pre-mRNA splicing in vivo
Zhao, X., & Yu, Y.-T. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl1084 · Cited by 89
Fragmentation of Replicating Chromosomes Triggered by Uracil in DNA
Kouzminova, E. A., & Kuzminov, A. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.10.044 · Cited by 69
Defects in 18 S or 28 S rRNA Processing Activate the p53 Pathway
Hölzel, M., Orban, M., Hochstatter, J., Michaela, R., Thomas, H., Anastassia, M., Kremmer, E., Längst, G., & Eick, D. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.054734 · Cited by 63
Self-citationCarneiro, T., Carvalho, C., Braga, J., Rino, J., Milligan, L., Tollervey, D. W., & Carmo‐Fonseca, M. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00120-07 · Cited by 52
RNA-Based 5-Fluorouracil Toxicity Requires the Pseudouridylation Activity of Cbf5p
Hoskins, J. W., & Butler, J. S. (2008) · Genetics · doi:10.1534/genetics.107.082727 · Cited by 45
AP endonuclease deficiency results in extreme sensitivity to thymidine deprivation
Dornfeld, K. J. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki975 · Cited by 18
Cited by
Boulon, S., Westman, B. J., Hutten, S., Boisvert, F.-M., & Lamond, A. I. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.024 · Cited by 1,103
The nucleolus as a multiphase liquid condensate
Lafontaine, D. L. J., Riback, J. A., Bascetin, R., & Brangwynne, C. P. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0272-6 · Cited by 1,051
Ribosome biogenesis in cancer: new players and therapeutic avenues
Pelletier, J., Thomas, G., & Volarević, S. (2018) · Nature Reviews Cancer · doi:10.1038/nrc.2017.104 · Cited by 812
Ribosomal proteins: functions beyond the ribosome
Zhou, X., Liao, W.-J., Liao, J.-M., Liao, P., & Lu, H. (2015) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjv014 · Cited by 743
Composition-dependent thermodynamics of intracellular phase separation
Riback, J. A., Zhu, L., Ferrolino, M. C., Tolbert, M., Mitrea, D. M., Sanders, D. W., Wei, M.-T., Kriwacki, R. W., & Brangwynne, C. P. (2020) · Nature · doi:10.1038/s41586-020-2256-2 · Cited by 691
Metadata
- Authors
- Burger, K., Mühl, B., Harasim, T., Rohrmoser, M., Malamoussi, A., Orban, M., Kellner, M., Gruber-Eber, A., Kremmer, E., Hölzel, M., & Eick, D.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2010-04
- Volume
- 285
- Issue
- 16
- Pages
- 12416-12425
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1980373840
- Cited by
- 458
- References
- 35
- FWCI
- 6.73
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.